Literature DB >> 17264516

Different migration of vascular smooth muscle cells from human coronary artery bypass vessels. Role of Rho/ROCK pathway.

Sabine Weiss1, Karin Frischknecht, Helen Greutert, Sravan Payeli, Jan Steffel, Thomas F Lüscher, Thierry P Carrel, Felix C Tanner.   

Abstract

BACKGROUND: We examined whether vascular smooth muscle (VSMC) or endothelial cell (EC) migration from internal mammary artery (MA) differed from VSMC or EC migration from saphenous vein (SV). METHODS AND
RESULTS: Migration to PDGF-BB (1-10 ng/ml) was lower in VSMC from MA than SV; however, attachment, movement without chemokine, and chemokinesis were identical. Unlike VSMC, migration of EC was similar in response to several mediators. Expression of PDGF receptor-beta was lower in VSMC from MA than SV, while alpha-receptor expression was higher. PDGF-BB-induced RhoA activity was lower in MA than SV, while basal activity was identical. Rosuvastatin and hydroxyfasudil impaired PDGF-BB-induced migration of VSMC from MA and SV. Mevalonate and geranylgeranylpyrophosphate rescued inhibition by rosuvastatin. PDGF-BB induced less stress fiber formation in VSMC from MA than SV. A dominant negative RhoA mutant inhibited stress fiber formation to PDGF-BB, while a constitutively active mutant resulted in maximal stress fiber formation in MA and SV. Rosuvastatin and hydroxyfasudil impaired PDGF-BB-induced stress fiber formation in MA and SV.
CONCLUSIONS: VSMC migration to PDGF-BB is lower in MA than SV, which is at least in part related to lower activity of the Rho/ROCK pathway. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264516     DOI: 10.1159/000099141

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  8 in total

1.  Alterations of the 5'untranslated region of SLC16A12 lead to age-related cataract.

Authors:  Jurian Zuercher; John Neidhardt; Istvan Magyar; Stephan Labs; Anthony T Moore; Felix C Tanner; Naushin Waseem; Daniel F Schorderet; Francis L Munier; Shomi Bhattacharya; Wolfgang Berger; Barbara Kloeckener-Gruissem
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-24       Impact factor: 4.799

2.  PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms.

Authors:  Li Li; Donald K Blumenthal; Christi M Terry; Yuxia He; Mary L Carlson; Alfred K Cheung
Journal:  J Cell Biochem       Date:  2011-01       Impact factor: 4.429

Review 3.  Vein graft failure: from pathophysiology to clinical outcomes.

Authors:  Margreet R de Vries; Karin H Simons; J Wouter Jukema; Jerry Braun; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2016-05-19       Impact factor: 32.419

Review 4.  Redox control of vascular smooth muscle migration.

Authors:  Alejandra San Martín; Kathy K Griendling
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

5.  LDL-induced impairment of human vascular smooth muscle cells repair function is reversed by HMG-CoA reductase inhibition.

Authors:  Teresa Padró; Roberta Lugano; Maisa García-Arguinzonis; Lina Badimon
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

6.  Resveratrol inhibits migration and Rac1 activation in EGF- but not PDGF-activated vascular smooth muscle cells.

Authors:  Mario Kumerz; Elke H Heiss; Daniel Schachner; Atanas G Atanasov; Verena M Dirsch
Journal:  Mol Nutr Food Res       Date:  2011-07-05       Impact factor: 5.914

7.  Versican is differentially regulated in the adventitial and medial layers of human vein grafts.

Authors:  Richard D Kenagy; Shinsuke Kikuchi; Steve P Evanko; Matthijs S Ruiter; Marco Piola; Alban Longchamp; Maurizio Pesce; Monica Soncini; Sébastien Deglise; Gianfranco B Fiore; Jacques-Antoine Haefliger; Tannin A Schmidt; Mark W Majesky; Michael Sobel; Thomas N Wight
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

8.  The role of Rho/Rho-kinase pathway and the neuroprotective effects of fasudil in chronic cerebral ischemia.

Authors:  Ya-Yun Yan; Xiao-Ming Wang; Yan Jiang; Han Chen; Jin-Ting He; Jing Mang; Yan-Kun Shao; Zhong-Xin Xu
Journal:  Neural Regen Res       Date:  2015-09       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.